178,95 €
178,95 €
inkl. MwSt.
Sofort per Download lieferbar
178,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
Als Download kaufen
178,95 €
inkl. MwSt.
Sofort per Download lieferbar
Abo Download
9,90 € / Monat*
*Abopreis beinhaltet vier eBooks, die aus der tolino select Titelauswahl im Abo geladen werden können.

inkl. MwSt.
Sofort per Download lieferbar

Einmalig pro Kunde einen Monat kostenlos testen (danach 9,90 € pro Monat), jeden Monat 4 aus 40 Titeln wählen, monatlich kündbar.

Mehr zum tolino select eBook-Abo
Jetzt verschenken
178,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
89 °P sammeln

  • Format: PDF


The book covers the complete field of testis cancer including the germ cell tumors and the stromal tumors, from epidemiology to new chemotherapeutic agents and schedules, throughout genetic features, risk factors, risk adapted treatments, role of different types of surgery and special clinical situations. Special attention is focused on fertility issues, late effects of the primary therapy and the economical aspects of the different treatment policies.
As a result of the third Consensus Conference, a consensual follow-up can be devised and a chapter dedicated to this controversial and not
…mehr

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 13.95MB
Produktbeschreibung
The book covers the complete field of testis cancer including the germ cell tumors and the stromal tumors, from epidemiology to new chemotherapeutic agents and schedules, throughout genetic features, risk factors, risk adapted treatments, role of different types of surgery and special clinical situations. Special attention is focused on fertility issues, late effects of the primary therapy and the economical aspects of the different treatment policies.

As a result of the third Consensus Conference, a consensual follow-up can be devised and a chapter dedicated to this controversial and not yet defined matter.

This book is the state-of-the-art reference text on testis cancer and is an essential resource for all urologists, medical oncologists and radio-oncologists.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GB, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

  • Produktdetails
  • Verlag: Springer-Verlag GmbH
  • Erscheinungstermin: 15.09.2010
  • Englisch
  • ISBN-13: 9781848003705
  • Artikelnr.: 37337812
Inhaltsangabe
Epidemiology and Natural History.- Histological Classification.- Risk factors and Genetical characterization.- Staging and Prognostic Systems.- The importance of Markers.- Primary Surgery.- Treatment: Non seminoma.- Treatment: Seminoma.- Treatment: Retroperitoneal Lymph Node Dissection.- Treatment: Non germ cell tumours.- Treatment: Extra-gonadal germ cell tumours.- Treatment of Residual Masses.- Diagnostic and treatment of Refractory Testis tumour.- Late recurrences.- Special situations - Bone and Brain metastases.- Late effect of primary treatment.- Fertility issues and testicular microlithiasis.- Cost adapted therapies.- Follow up.- Future perspectives.
Rezensionen
From the reviews: "This is an excellent resource not only for diagnosis and staging, but also as an overview of contemporary management. ... The book is intended for clinicians who wish to review and broaden their knowledge in this area. ... Each chapter in this book is well written and provides excellent discourse on its topic. This is a very good resource for clinicians who seek an overview of the relevant multifaceted aspects of testis cancer." (Timothy J. Kim, Doody's Review Service, August, 2011) "M. Pilar Laguna, P. Albers, C. Bokeleyer and J. P. Richie developed a transatlantic cooperation and wrote this outstanding book with the help of more than 50 recognised experts. All medical specialities involved in testis cancer management were represented ... . All aspects of testis cancer were examined with the main contents divided into six parts. ... This textbook was intended for urologists and all physicians involved in testis cancer management, a many will find practical information in this publication." (Paul Meria, European Urology Today, April/May, 2011)